India  

AstraZeneca

British pharmaceutical company

AstraZeneca    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

AstraZeneca: British pharmaceutical company
AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

1
shares
ShareTweetSavePostSend
 

You Might Like


Govt body's procedures means people with cancer aren't getting drug - AstraZeneca boss

govt body's procedures means people with cancer aren't getting drug - astrazeneca boss
The chief executive of AstraZeneca has criticised a public health body for refusing to make one of its breast cancer treatments available to NHS patients in England and Wales.
Sky News - Published

1 in 3 Covaxin recipients hit by adverse events: Study

Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual..
IndiaTimes - Published

Stopped producing Covishield in Dec 2021: SII after AstraZeneca recall

UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to disclose that it had stopped..
IndiaTimes - Published

SII stopped manufacturing Covishield since December 2021, says 'disclosed side effects details in packaging insert'

SII stopped Covishield extra doses due to lawsuit, disclosed rare Thrombosis. Advocates govt collaboration. AstraZeneca withdraws Vaxzevria marketing authorisations globally. European Medicines Agency..
IndiaTimes - Published

AstraZeneca starts worldwide withdrawal of COVID vaccine

AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy.
Sky News - Published

'Safety first', says Bharat Biotech amid AstraZeneca row


IndiaTimes - Published

AstraZeneca admits Covishield vaccines raises rare side-effects risk. How worried should you be?

In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield.
DNA - Published

'A shadow of what I was': Dad who suffered brain injury days after getting COVID jab sues AstraZeneca

A dad who suffered a brain injury just days after receiving a British-developed COVID vaccine has told Sky News he would never have had the jab if he had known of the risk of rare but serious side..
Sky News - Published

The boss of AstraZeneca could earn £18.5m this year - but he may be underpaid

The drugmaker AstraZeneca (AZ) promised this morning to raise its annual dividend by 7% this year.
Sky News - Published

Astra Zeneca gets nod for anticoagulant drug

AstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organisation for the import and marketing of Andexanet Alfa. The therapy addresses..
IndiaTimes - Published

'Healthy' doctor died after 'very rare' reaction to AstraZeneca COVID jab

'healthy' doctor died after 'very rare' reaction to astrazeneca covid jab
A "fit and healthy" doctor who was one of the first people to be given the AstraZeneca COVID vaccination died after a "rare" severe reaction to the jab, a coroner has ruled.
Sky News - Published

AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer


IndiaTimes - Published

Hunt faces calls to cut taxes after AstraZeneca snubs UK for £320m factory in Ireland

hunt faces calls to cut taxes after astrazeneca snubs uk for £320m factory in ireland
Tory MPs have stepped up calls for the government to cut taxes after pharmaceutical giant AstraZeneca overlooked Britain for a new £320m drug factory.
Sky News - Published

India to start Covid mix-and-match booster vaccines on Friday

India said on Wednesday that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main shots, Covaxin and AstraZeneca's..
IndiaTimes - Published

ICMR study shows increase in antibodies after receiving Covaxin booster dose, says MoS Health

International data available on booster doses of AstraZeneca & Covishield suggests 3 to 4 fold increase in antibody levels after their administration.
DNA - Published

Hundreds of thousands probably died due to 'bad behaviour' over Oxford vaccine, says scientist

hundreds of thousands probably died due to 'bad behaviour' over oxford vaccine, says scientist
A scientist who worked on the AstraZeneca vaccine has said "hundreds of thousands of people" probably died because some politicians and scientists unfairly damaged its reputation.
Sky News - Published

Serum Institute has applied for full market authorisation of Covishield: CEO Adar Poonawala

Serum Institute has applied to the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield vaccine, company's CEO Adar Poonawalla..
IndiaTimes - Published

India-Bangladesh bonhomie scaled new heights as 2021 marked 50 years of ties

The year began on a promising note as Bangladesh PM Sheikh Hasina thanked her Indian counterpart Narendra Modi for sending over two million doses of AstraZeneca-Oxford University vaccine Covishield, as..
IndiaTimes - Published

UK marks one-year anniversary of approving Oxford/AstraZeneca COVID vaccine

uk marks one-year anniversary of approving oxford/astrazeneca covid vaccine
Boris Johnson has praised the Oxford/AstraZeneca vaccine for saving "many millions of lives" as the UK marks becoming the first country to approve the COVID vaccine exactly one year ago.
Sky News - Published

Demand still strong for India-made AstraZeneca vaccine doses - Covax's Gavi


IndiaTimes - Published

Next virus could be 'more contagious' and 'more lethal', warns Oxford vaccine creator

next virus could be 'more contagious' and 'more lethal', warns oxford vaccine creator
The next pandemic could be more deadly than COVID-19, according to one of the scientists behind the Oxford-AstraZeneca vaccine.
Sky News - Published

Covid-19: A wide range of vaccines act as booster to AstraZeneca, Pfizer shots, says study

Up to six different Covid-19 boosters were found to be safe, and provoked strong immune responses in people who have previously received a two-dose course of the Oxford-AstraZeneca-developed..
IndiaTimes - Published

'Trigger' behind extremely rare AstraZeneca vaccine blood clots may have been discovered

'trigger' behind extremely rare astrazeneca vaccine blood clots may have been discovered
The "trigger" behind extremely rare blood clot complications stemming from the Oxford/AstraZeneca vaccine may have been discovered, according to new research.
Sky News - Published

Blood clots from Astrazeneca jab killed mother, coroner finds

blood clots from astrazeneca jab killed mother, coroner finds
A woman who died from complications and clotting due to the AstraZeneca COVID vaccine was a "hero" for getting it, her husband said, as "lessons have been learned".
Sky News - Published

AstraZeneca's pledge to poorer nations as it seeks COVID jab profits from next year

astrazeneca's pledge to poorer nations as it seeks covid jab profits from next year
The chief executive of AstraZeneca (AZ) has told Sky News that the company's decision to begin seeking a modest profit from its COVID vaccine is unlikely to kick in until next year.
Sky News - Published

AstraZeneca eyes 'modest' profit from COVID-19 vaccine

astrazeneca eyes 'modest' profit from covid-19 vaccine
Drugs firm AstraZeneca has said it plans to start earning a "modest" profit from its COVID-19 vaccine having previously sold it at cost.
Sky News - Published